酸离子调节两个克拉夫兰酸耐药β-乳酸酶突变体中的酶活性和表观效应
Marko Radojković1, Saar F Koene1, Aleksandra Chikunova1
1Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
Protein science : a publication of the Protein Society
|October 11, 2025
概括
表观症,或非添加性突变效应,影响酶进化和抗菌素耐药性. 这项研究揭示了表皮病如何影响酶适应性和活性,为抵抗机制提供了洞察力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 进化生物学 进化生物学
背景情况:
- 突变之间的非添加性相互作用 (epistasis) 复杂化了预测酶进化的过程.
- 血清β-乳酸酶表现出表性作用,导致抗菌素耐药性.
- 之前的研究表明,阳性表观增强了BlaC.中的克拉夫兰酸抵抗力.
研究的目的:
- 在BlaC酶变体中研究表观症的分子机制.
- 在I105Y-S130G和I105G-G132N双变异体中分析表皮症.
- 了解表皮病在酶适应性和抗菌素耐药性中的作用.
主要方法:
- 生物化学测定 生物化学测定
- 结构分析 结构分析
- 酶动力学 酶动力学
- 进行热稳定性分析.
主要成果:
- 在I105G-G132N中观察到的催化活性的表观补偿,取决于缓冲条件.
- 在I105G-G132N变种中观察到对热稳定性的非添加效应.
- 突变和活性部位修饰之间的相互作用会影响酶特性.
结论:
- 酶进化中的表观性植根于多种酶特征.
- 了解表观症对于预测酶进化和抗菌素耐药性至关重要.
- 这项研究阐明了氨酸β-乳酸酶中的表观症机制.
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
518
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
518
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Protein Kinases and Phosphatases
14.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.9K
Allosteric Regulation
62.9K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K


